CD8A and cancer: The abundance of tumor-infiltrating lymphocytes (TILs), and CD8+ T cells, in particular, is associated with favorable clinical prognoses in a wide range of solid malignancies, including melanoma and cancers of the head and neck, breast, bladder, ovaries, and colon (2).